# InvAscent Capital Partners

InvAscent Capital Partners is a Private Equity based in Hyderabad, India.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Hyderabad, India
- **Region:** Asia
- **Address:** Hyderabad, India
- **Founded:** 2005
- **Assets under management:** Undisclosed
- **Website:** www.invascent.com
- **LinkedIn:** https://www.linkedin.com/company/invascent-advisory-services-india-private-limited

## Regulatory record

- **Reports private funds:** No

## About

InvAscent Capital Partners is a private equity firm based in Hyderabad, India. It focuses on growth investments. The firm oversees approximately $650 million in assets, with $116.2 million in available capital.

## Sectors

- Pharmaceuticals
- Healthcare Delivery
- Medical Devices
- Animal Health
- Specialty Ingredients
- HealthTech

## Questions

### What is InvAscent Capital Partners' investment strategy?

InvAscent pursues growth equity investments in India's healthcare sector. The firm targets companies in pharmaceutical manufacturing, specialty hospital chains, diagnostic-lab networks, and medical-device production. The emphasis is on asset-heavy, regulated businesses that need capital to scale manufacturing capacity or care-delivery infrastructure rather than early-stage drug discovery or technology-platform bets.

### Where does InvAscent invest geographically?

The firm invests solely in India. Portfolio companies frequently serve both domestic patients and international export markets regulated by agencies such as the US FDA and the European Medicines Agency. InvAscent's headquarters in Hyderabad—India's generic-pharmaceutical manufacturing hub—anchors its geographic and sector concentration.

### What sectors does InvAscent explicitly avoid?

InvAscent avoids early-stage pharmaceutical R&D and biotechnology platforms where returns depend on clinical-trial outcomes. The firm also does not invest outside healthcare. Generalist consumer, technology, or infrastructure businesses fall outside its mandate, as do pure-play software or health-tech platforms without a physical care-delivery or manufacturing component.

## Related profiles

- [Invariantes Fund](https://altss.com/profile/invariantes-fund)
- [Inven Capital](https://altss.com/profile/inven-capital)

---

Last updated: 2026-07-11T02:56:57.000Z

Canonical page: https://altss.com/profile/invascent-capital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology